Evidence map›Paper›PMID 34182772›Full record

ArticlemBio2021

Protein Prenylation and Hsp40 in Thermotolerance of Plasmodium falciparum Malaria Parasites.

Emily S Mathews, Andrew J Jezewski, Audrey R Odom John

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Evolutionary Trajectory ofBiomedicines · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Antimicrobial agents and chemotherapy · 2023
    Article
  12. Article
  13. Review
  14. The human malaria parasiteProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  15. Article
  16. Catalytic Properties of Caseinolytic Protease Subunit ofMolecules (Basel, Switzerland) · 2022
    Article
  17. Frontiers in cell and developmental biology · 2022
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Emily S MathewsDepartment of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
Andrew J JezewskiDepartment of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
Audrey R Odom JohnDepartment of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
Children's Hospital of Philadelphia · USUniversity of Iowa · USWashington University in St. Louis · US

Funding

TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGYT32GM007067 · NIGMS · WASHINGTON UNIVERSITY · PI TRUE-KROB, HEATHER L · 1985 to 2020
$20.4M
Infectious Diseases/Basic Microbial Pathogenic MechanismsT32AI007172 · NIAID · WASHINGTON UNIVERSITY · PI Daniel E. Goldberg, JENNIFER A PHILIPS · 1985 to 2026
$13.0M
TRAINING IN MECHANISMS OF PARASITISMT32AI007511 · NIAID · UNIVERSITY OF IOWA · PI BUTLER, NOAH SULLIVAN, WEBER, MARY · 1996 to 2025
$8.1M
MEP pathway resistance in Plasmodium falciparumR01AI103280 · NIAID · WASHINGTON UNIVERSITY · PI Audrey Ragan Odom John · 2013 to 2026
$5.5M
Inhibition of MEP pathway Isoprenoid BiosynthesisR01AI123433 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI DOWD, CYNTHIA SCHIECK, MEYERS, MARVIN J · 2016 to 2020
$2.6M
Towards noninvasive diagnosis of malariaR21AI144472 · NIAID · WASHINGTON UNIVERSITY · PI ODOM JOHN, AUDREY RAGAN · 2019 to 2020
$485k
SELECTIVE INHIBITION OF THE P. FALCIPARUM GLUCOSE TRANSPORTER PFHTR21AI130584 · NIAID · WASHINGTON UNIVERSITY · PI HRUZ, PAUL W · 2018 to 2019
$419k
GE AKTAEXPLORER CHROMOTOGRAPHY SYSTEMS10RR026891 · NCRR · WASHINGTON UNIVERSITY · PI ODOM JOHN, AUDREY RAGAN · 2010 to 2010
$122k
Heat Shock Protein Prenylation in Malaria ParasitesF32AI138373 · NIAID · WASHINGTON UNIVERSITY · PI MATHEWS, EMILY S · 2019 to 2020
$74k
NCRR NIH HHS S10 RR026891NIAID NIH HHS F32 AI138373NIAID NIH HHS R01 AI103280NIAID NIH HHS R01 AI123433NIAID NIH HHS R21 AI130584NIAID NIH HHS R21 AI144472NIAID NIH HHS T32 AI007172NIAID NIH HHS T32 AI007511NIGMS NIH HHS T32 GM007067
6 · The paper itself

Abstract

During its complex life cycle, the malaria parasite survives dramatic environmental stresses, including large temperature shifts. Protein prenylation is required during asexual replication of Plasmodium falciparum, and the canonical heat shock protein 40 protein (HSP40; PF3D7_1437900) is posttranslationally modified with a 15-carbon farnesyl isoprenyl group. In other organisms, farnesylation of Hsp40 orthologs controls their localization and function in resisting environmental stress. In this work, we find that plastidial isopentenyl pyrophosphate (IPP) synthesis and protein farnesylation are required for malaria parasite survival after cold and heat shock. Furthermore, loss of HSP40 farnesylation alters its membrane attachment and interaction with proteins in essential pathways in the parasite. Together, this work reveals that farnesylation is essential for parasite survival during temperature stress. Farnesylation of HSP40 may promote thermotolerance by guiding distinct chaperone-client protein interactions.

Indexed as

Protein PrenylationThermotoleranceErythrocytesHeat-Shock ResponseHemiterpenesHost-Parasite InteractionsHSP40 Heat-Shock ProteinsHumansLife Cycle StagesOrganophosphorus CompoundsPlasmodium falciparumProtozoan ProteinsHemiterpenesHSP40 Heat-Shock Proteinsisopentenyl pyrophosphateOrganophosphorus CompoundsProtozoan Proteinsfarnesylationheat shockisoprenoidsmalariaPlasmodium falciparumprotein chaperone

Identifiers

PMID34182772
PMCPMC8262983
OpenAlexW3173488702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.